Table 1 Patient’s laboratory data at admission

White blood cells

7100/μL

4000–8500/μL

Red blood cells

583 × 10⁴/μL

4.15–5.50 × 10⁴/μL

Hemoglobin

16.5 g/dL

13.5–17.5 g/dL

Platelets

24.1 × 10⁴/μL

12–36 × 10⁴/μL

Prothrombin time

88.7%

80–125%

Sodium

140.9 mEq/L

136–147 mEq/L

Potassium

4.01 mEq/L

3.5–5.0 mEq/L

Chloride

102.5 mEq/L

98–108 mEq/L

Total protein

8.0 g/dL

6.5–8.2 g/dL

Albumin

4.5 g/dL

3.8–5.3 g/dL

Total bilirubin

1.00 mg/dL

0.3–1.2 mg/dL

Aspartate aminotransferase

38 U/L

8–40 U/L

Alanine aminotransferase

105 U/L

5–45 U/L

Alkaline phosphatase

475 U/L

100–340 U/L

Gamma-glutamyl transpeptidase

127 U/L

0–75 U/L

Lactate dehydrogenase

205 U/L

115–245 U/L

Cholinesterase

467 U/L

239–485 U/L

Total cholesterol

254 mg/dL

130–219 mg/dL

High-density lipoprotein cholesterol

49 mg/dL

40–85 mg/dL

Low-density lipoprotein cholesterol

168 mg/dL

70–139 mg/dL

Triglyceride

212 mg/dL

30–149 mg/dL

Blood urea nitrogen

11.5 mg/dL

8.0–23.0 mg/dL

Creatinine

0.70 mg/dL

0.61–1.08 mg/dL

C-reactive protein

1.32 mg/dL

0–0.30 mg/dL

Hemoglobin A1c

6.2%

< 6.0%

Hepatatis B surface antigen

Negative

Negative

Hepatitis C virus antibody

Negative

Negative

Anti-nuclear antibody

< × 40

< × 40

Anti-mitochondrial M2 antibody

< 1.5 INDEX

0–6.99 INDEX

Alfa-fetoprotein

< 2.00 ng/mL

0–10 ng/mL

Carcinoembryonic antigen

1.8 ng/mL

0–5 ng/mL

Carbohydrate antigen 19-9

4.58 U/mL

0–2 U/mL

Protein induced by vitamin K absence or antagonist-II

92 mAU/mL

< 40 mAU/mL

Neuron-specific enolase

10.4 ng/mL

< 16.3 ng/mL

Soluble interleukin-2 receptor

397 U/mL

145–519 U/mL

Indocyanine green 15-min retention rate

15.0%

< 10%